Drug interactions Curcumin has been found to inhibit platelet aggregation in vitro (113, 114), suggesting a potential for curcumin supplementation to increase the risk of bleeding in people taking anticoagulant or antiplatelet medications, such as aspirin, clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), and warfarin (Coumadin)
The two therapies work in tandem: one purifies at the cellular level, the other clears the pathways that carry waste away
These lipotropic agents are structurally and functionally closely related to the B-vitamins and are involved in the homeostasis of energy production from fat
By restoring or mimicking these peptides, therapy works to promote repair, rejuvenation, and overall wellness